Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.

Mikako Ogawa(Hokkaido University), Hideo Saji(Kyoto University), Takahiro Mukai(Kyushu University), Masashi Shiomi(Toujinkai Hospital), Kentaro Hatano, Kengo Ito(National Center for Geriatrics and Gerontology), Yasuhiro Magata(National Center for Geriatrics and Gerontology), Takashi Kato(National Center for Geriatrics and Gerontology), Seigo Ishino(Takeda (United States))
PubMed
November 1, 2006
Cited by 121

Related Papers

High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment
|PLoS ONE|2013|388
Somatosensory Homunculus as Drawn by MEG
|NeuroImage|1998|342
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study
|Brain|1999|271